EP0034-#A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN PEDIATRIC EPILEPSY SUBJECTS WITH PARTIAL-ONSET SEIZURES

Grants and Contracts Details

StatusFinished
Effective start/end date11/20/1311/30/16

Funding

  • UCB Pharma (domestic): $10,531.00